Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Alpaca Nanobody (VHH) Secondary Antibody (NabFab)

Catalog #:   RWK30501 Specific References (28) DATASHEET
Host species: Mouse
Isotype: IgG2a
Applications: ELISA, FCM, IF, IHC, WB
Overview

Catalog No.

RWK30501

Species reactivity

Lama glama (Llama)

Host species

Mouse

Isotype

IgG2a

Clonality

Monoclonal

Applications

ELISA, FCM, IF, IHC, WB

Target

Alpaca, Nanobody, VHH, Secondary Antibody

Concentration

1.18 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

NabFab

Note

For research use only.

Data Image
  • SEC-HPLC
    The purity of this product is >95% as determined by SEC-HPLC.
References

Domain swapping of a llama VHH domain builds a crystal-wide beta-sheet structure., PMID:15094039

Heating as a rapid purification method for recovering correctly-folded thermotolerant VH and VHH domains., PMID:17257422

An intrabody based on a llama single-domain antibody targeting the N-terminal alpha-helical multimerization domain of HIV-1 rev prevents viral production., PMID:20406803

Structures of a key interaction protein from the Trypanosoma brucei editosome in complex with single domain antibodies., PMID:20969962

Atomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic beta2-microglobulin variant., PMID:21220305

Analysis and modeling of the variable region of camelid single-domain antibodies., PMID:21525384

Antibody engineering reveals the important role of J segments in the production efficiency of llama single-domain antibodies in Saccharomyces cerevisiae., PMID:22143875

Llama-derived single domain antibodies specific for Abrus agglutinin., PMID:22174977

Semiautomated panning of naive camelidae libraries and selection of single-domain antibodies against peptide antigens., PMID:22886248

Selection and evaluation of single domain antibodies toward MS2 phage and coat protein., PMID:22898187

Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells., PMID:22918079

Structure of a low-melting-temperature anti-cholera toxin: llama V(H)H domain., PMID:23385744

Production, crystallization and X-ray diffraction analysis of two nanobodies against the Duffy binding-like (DBL) domain DBL6ℇ-FCR3 of the Plasmodium falciparum VAR2CSA protein., PMID:23519802

A stably expressed llama single-domain intrabody targeting Rev displays broad-spectrum anti-HIV activity., PMID:25453342

Can template-based protein models guide the design of sequence fitness for enhanced thermal stability of single domain antibodies?, PMID:26374895

Structural Effects of Two Camelid Nanobodies Directed to Distinct C-Terminal Epitopes on α-Synuclein., PMID:27096466

Structural analysis of nested neutralizing and non-neutralizing B cell epitopes on ricin toxin's enzymatic subunit., PMID:27159829

Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection., PMID:27550346

Analysis of the binding loops configuration and surface adaptation of different crystallized single-domain antibodies in response to various antigens., PMID:27862476

A toolbox of anti-mouse and anti-rabbit IgG secondary nanobodies., PMID:29263082

Sandwich pair nanobodies, a potential tool for electrochemical immunosensing serum prostate-specific antigen with preferable specificity., PMID:29935325

CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry., PMID:30342024

A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants., PMID:34654739

VHH Structural Modelling Approaches: A Critical Review., PMID:35409081

Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site., PMID:35413243

A Novel Cost-Effective Nanobody against Fumonisin B1 Contaminations: Efficacy Test in Dairy Milk and Chickens., PMID:36548718

VHH CDR-H3 conformation is determined by VH germline usage., PMID:37598276

Evaluation of the Potential Impact of In Silico Humanization on VHH Dynamics., PMID:37834033

Datasheet
$ 328
Product specifications
100 μg 328 1 mg 1640

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Alpaca Nanobody (VHH) Secondary Antibody (NabFab) [RWK30501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only